[{"id":"bc9cc80a-7730-40df-99dd-e63d1e1590c4","acronym":"CyGIM","url":"https://clinicaltrials.gov/study/NCT05657080","created_at":"2022-12-20T15:59:29.441Z","updated_at":"2024-07-02T16:35:04.863Z","phase":"","brief_title":"Cytosponge for Gastric Intestinal Metaplasia","source_id_and_acronym":"NCT05657080 - CyGIM","lead_sponsor":"University of Cambridge","biomarkers":" TFF3","pipe":"","alterations":" ","tags":["TFF3"],"overall_status":"Recruiting","enrollment":" Enrollment 226","initiation":"Initiation: 10/16/2023","start_date":" 10/16/2023","primary_txt":" Primary completion: 09/30/2024","primary_completion_date":" 09/30/2024","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-05-08"},{"id":"6bf48b0d-362b-499d-8367-d5bb3d56de12","acronym":"REACT","url":"https://clinicaltrials.gov/study/NCT03366012","created_at":"2022-06-29T00:54:26.254Z","updated_at":"2024-07-02T16:35:38.450Z","phase":"","brief_title":"Rapid Assessment of Esophageal Adenocarcinoma Risk Test","source_id_and_acronym":"NCT03366012 - REACT","lead_sponsor":"Columbia University","biomarkers":" TFF3","pipe":"","alterations":" ","tags":["TFF3"],"overall_status":"Suspended","enrollment":" Enrollment 100","initiation":"Initiation: 08/01/2018","start_date":" 08/01/2018","primary_txt":" Primary completion: 08/01/2024","primary_completion_date":" 08/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2023-08-31"},{"id":"faf6144b-2a04-4dff-89e7-a990e4642bd4","acronym":"","url":"https://clinicaltrials.gov/study/NCT03046745","created_at":"2021-01-18T15:00:17.219Z","updated_at":"2024-07-02T16:36:44.931Z","phase":"","brief_title":"Gastric Cancer Registry for Epidemiology and Molecular Risk Factor","source_id_and_acronym":"NCT03046745","lead_sponsor":"Kyungpook National University Hospital","biomarkers":" TFF3","pipe":"","alterations":" ","tags":["TFF3"],"overall_status":"Unknown status","enrollment":" Enrollment 9000","initiation":"Initiation: 08/01/2016","start_date":" 08/01/2016","primary_txt":" Primary completion: 04/01/2021","primary_completion_date":" 04/01/2021","study_txt":" Completion: 04/01/2022","study_completion_date":" 04/01/2022","last_update_posted":"2020-05-19"},{"id":"46796604-a010-44c5-afc3-7fe46df815ca","acronym":"","url":"https://clinicaltrials.gov/study/NCT03894384","created_at":"2021-01-18T19:10:58.464Z","updated_at":"2024-07-02T16:36:51.523Z","phase":"","brief_title":"The Value of TFF3 in Diagnosis of Gastric Cancer","source_id_and_acronym":"NCT03894384","lead_sponsor":"Assiut University","biomarkers":" TFF3","pipe":"","alterations":" ","tags":["TFF3"],"overall_status":"Recruiting","enrollment":" Enrollment 90","initiation":"Initiation: 12/01/2019","start_date":" 12/01/2019","primary_txt":" Primary completion: 11/01/2021","primary_completion_date":" 11/01/2021","study_txt":" Completion: 11/01/2022","study_completion_date":" 11/01/2022","last_update_posted":"2020-01-09"},{"id":"92b4ea40-f078-45e2-8677-8863cdabf348","acronym":"","url":"https://clinicaltrials.gov/study/NCT03112733","created_at":"2021-01-18T15:20:11.059Z","updated_at":"2024-07-02T16:37:02.408Z","phase":"","brief_title":"Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers","source_id_and_acronym":"NCT03112733","lead_sponsor":"Ilker Kahramanoglu","biomarkers":" ROMO1 • TFF3 • SFRP4","pipe":"","alterations":" ","tags":["ROMO1 • TFF3 • SFRP4"],"overall_status":"Unknown status","enrollment":" Enrollment 171","initiation":"Initiation: 04/04/2017","start_date":" 04/04/2017","primary_txt":" Primary completion: 06/21/2018","primary_completion_date":" 06/21/2018","study_txt":" Completion: 05/30/2019","study_completion_date":" 05/30/2019","last_update_posted":"2019-02-26"}]